Table 1 Description of Patients on Once Daily Vancomycin Prophylaxis (n = 20)
From: Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
Demographics | |
Age, median (min, max) | 80 years (53, 92) |
Male | 7 (35%) |
C. difficile Infection (CDI) Episodes, median (min, max) | 4 (2, 11) |
Previous CDI Treatment | |
Metronidazole | 18 (90%) |
Courses of Metronidazole, median (min, max) | 2 (1, 5) |
Vancomycin | 20 (100%) |
Courses of Vancomycin, median (min, max) | 3 (1, 11) |
Fidaxomicin | 4 (20%) |
Fecal Microbiota Transplantation (FMT) | 15 (75%) |
Number of FMTs, median (min, max) | 3 (1, 12) |
Comorbidities | |
Cardiac | 13 (65%) |
Chronic Obstructive Pulmonary Disease | 8 (40%) |
Chronic Kidney Disease | 7 (35%) |
Diabetes Type 2 | 5 (25%) |
Gastroesophageal Reflux Disease | 7 (35%) |